Clinical Trial Update: Autologous Stromal Vascular Fraction of Cells for Treatment of Knee Articular Cartilage Dystrophy [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluates autologous stromal vascular fraction cells for knee osteoarthritis. The trial status is listed as unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Knee Osteoarthritis
• Osteoarthritis

Drugs mentioned

• Autologous stromal vascular fraction (SVF) cells

Snippet

Sponsor: Central Clinical Hospital w/Outpatient Health Center of Business Administration for the President of Russian Federation | Conditions: Knee Osteoarthritis | Phase 2 | Status: UNKNOWN